SCHEMBL1089203

SCHEMBL1089203

COc1cccc(CN(C)CCNc2nccc(N3CCCCCC3)n2)c1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.48
ALDH1A1 P00352 3/20 0.45
TP53 P04637 2/20 0.45
MAPT P10636 2/20 0.45
MAPK1 P28482 2/20 0.45
HTT P42858 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
KDM4E B2RXH2 1/20 0.45
NPC1 O15118 1/20 0.45
ALOX15 P16050 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
HRH4 Q9H3N8 5/20 0.41
HRH3 Q9Y5N1 3/20 0.41
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41
SLC6A2 P23975 1/20 0.41
HRH2 P25021 1/20 0.41
HTR1D P28221 1/20 0.41
HTR2A P28223 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1089728 0.82 CXCR4 (0.52) CXCR4HRH4HRH3ADRA2BADRA2C
SCHEMBL1089332 0.82 ADRA2B (0.50) CXCR4HRH4HRH3ADRA2BADRA2C
SCHEMBL1088455 0.81 CXCR4 (0.50) CXCR4ALOX15NPSR1HRH4HRH3
SCHEMBL1089201 0.81 CXCR4 (0.46) CXCR4HRH4HRH3ADRA2BADRA2C
SCHEMBL1089043 0.79 HRH4 (0.60) CXCR4ALDH1A1HTTHRH4HRH3
SCHEMBL1089331 0.77 MEN1 (0.54) CXCR4ALDH1A1TP53MAPTMAPK1
SCHEMBL1089557 0.76 KDM4E (0.45) CXCR4ALDH1A1TP53MAPTMAPK1
SCHEMBL1089389 0.76 CXCR4 (0.54) CXCR4HRH4HRH3ADRA2BADRA2C
SCHEMBL1090045 0.76 CXCR4 (0.62) CXCR4HRH4HRH3ADRA2BADRA2C
SCHEMBL1090240 0.76 CXCR4 (0.47) CXCR4ALDH1A1HTTHRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885ALDH1A1 916/4885TP53 1740/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 CXCR4 1/4885ALDH1A1 916/4885TP53 1740/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885ALDH1A1 916/4885TP53 1740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.